{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:56:17Z","timestamp":1793051777803,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T00:00:00Z","timestamp":1728259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T00:00:00Z","timestamp":1728259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170078"],"award-info":[{"award-number":["82170078"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81900063"],"award-info":[{"award-number":["81900063"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-024-05655-0","type":"journal-article","created":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T19:01:37Z","timestamp":1728327697000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Albendazole ameliorates aerobic glycolysis in myofibroblasts to reverse pulmonary fibrosis"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7189-8637","authenticated-orcid":false,"given":"Chenxi","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihui","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congjian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuetao","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianlai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangning","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huilan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,7]]},"reference":[{"issue":"4","key":"5655_CR1","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1183\/13993003.00957-2022","volume":"61","author":"AJ Podolanczuk","year":"2023","unstructured":"Podolanczuk AJ, Thomson CC, Remy-Jardin M, et al. Idiopathic pulmonary fibrosis: state of the art for 2023. Eur Respir J. 2023;61(4):78.","journal-title":"Eur Respir J"},{"issue":"3","key":"5655_CR2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1183\/13993003.03697-2020","volume":"60","author":"Y Wang","year":"2022","unstructured":"Wang Y, Zhang L, Huang T, et al. The methyl-CpG-binding domain 2 facilitates pulmonary fibrosis by orchestrating fibroblast to myofibroblast differentiation. Eur Respir J. 2022;60(3):65.","journal-title":"Eur Respir J"},{"issue":"5","key":"5655_CR3","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/mt.2016.36","volume":"24","author":"Y Yao","year":"2016","unstructured":"Yao Y, Wang Y, Zhang Z, et al. Chop deficiency protects mice against bleomycin-induced pulmonary fibrosis by attenuating m2 macrophage production. Mol Ther. 2016;24(5):915\u201325.","journal-title":"Mol Ther"},{"key":"5655_CR4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2021-066354","volume":"377","author":"GY Liu","year":"2022","unstructured":"Liu GY, Budinger GRS, Dematte JE. Advances in the management of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis. BMJ. 2022;377: e066354.","journal-title":"BMJ"},{"issue":"2","key":"5655_CR5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.pccm.2023.05.002","volume":"1","author":"S Almuntashiri","year":"2023","unstructured":"Almuntashiri S, Alhumaid A, Zhu Y, et al. TIMP-1 and its potential diagnostic and prognostic value in pulmonary diseases. Chin Med J Pulm Crit Care Med. 2023;1(2):67\u201376.","journal-title":"Chin Med J Pulm Crit Care Med"},{"issue":"1","key":"5655_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.pccm.2024.02.001","volume":"2","author":"L Yao","year":"2024","unstructured":"Yao L, Xu Z, Davies DE, Jones MG, Wang Y. Dysregulated bidirectional epithelial-mesenchymal crosstalk: a core determinant of lung fibrosis progression. Chin Med J Pulm Crit Care Med. 2024;2(1):27\u201333.","journal-title":"Chin Med J Pulm Crit Care Med"},{"issue":"2","key":"5655_CR7","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.pccm.2024.04.003","volume":"2","author":"Z Zheng","year":"2024","unstructured":"Zheng Z, Peng F, Zhou Y. Biomarkers in idiopathic pulmonary fibrosis: Current insight and future direction. Chin Med J Pulm Crit Care Med. 2024;2(2):72\u20139.","journal-title":"Chin Med J Pulm Crit Care Med"},{"issue":"13","key":"5655_CR8","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.1016\/j.celrep.2018.03.010","volume":"22","author":"T Xie","year":"2018","unstructured":"Xie T, Wang Y, Deng N, et al. Single-cell deconvolution of fibroblast heterogeneity in mouse pulmonary fibrosis. Cell Rep. 2018;22(13):3625\u201340.","journal-title":"Cell Rep"},{"key":"5655_CR9","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.2147\/IJN.S444470","volume":"19","author":"C Zeng","year":"2024","unstructured":"Zeng C, Wang Q, Liu X, et al. Localized administration of Bcar3 siRNA via nano-self-assembly to treat idiopathic pulmonary fibrosis by disrupting macrophage-fibroblast crosstalk. Int J Nanomed. 2024;19:1827\u201342.","journal-title":"Int J Nanomed"},{"issue":"1","key":"5655_CR10","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/s41467-021-27684-9","volume":"13","author":"Y Hu","year":"2022","unstructured":"Hu Y, Wang Q, Yu J, et al. Tartrate-resistant acid phosphatase 5 promotes pulmonary fibrosis by modulating \u03b2-catenin signaling. Nat Commun. 2022;13(1):114.","journal-title":"Nat Commun"},{"issue":"7","key":"5655_CR11","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1093\/cid\/ciab730","volume":"74","author":"J Jacob","year":"2022","unstructured":"Jacob J, Steel A, Lin Z, Berger F, Z\u00f6eller K, Jarvi S. Clinical Efficacy and Safety of Albendazole and Other Benzimidazole Anthelmintics for Rat Lungworm Disease (Neuroangiostrongyliasis): A Systematic Analysis of Clinical Reports and Animal Studies. Clin Infect Dis. 2022;74(7):1293\u2013302.","journal-title":"Clin Infect Dis"},{"issue":"32","key":"5655_CR12","doi-asserted-by":"publisher","first-page":"26648","DOI":"10.1021\/acsami.7b05292","volume":"9","author":"Y Tang","year":"2017","unstructured":"Tang Y, Liang J, Wu A, et al. Co-delivery of trichosanthin and albendazole by nano-self-assembly for overcoming tumor multidrug-resistance and metastasis. ACS Appl Mater Interfaces. 2017;9(32):26648\u201364.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"2","key":"5655_CR13","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1093\/jac\/41.2.145","volume":"41","author":"VP Albendazole","year":"1998","unstructured":"Albendazole VP. J Antimicrob Chemother. 1998;41(2):145\u20137.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"5655_CR14","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1126\/sciadv.abb6075","volume":"7","author":"Y Wang","year":"2021","unstructured":"Wang Y, Zhang L, Wu G-R, et al. MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program. Sci Adv. 2021;7(1):345.","journal-title":"Sci Adv"},{"key":"5655_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2021.148041","volume":"790","author":"M Yang","year":"2021","unstructured":"Yang M, Wang D, Gan S, et al. Triiodothyronine ameliorates silica-induced pulmonary inflammation and fibrosis in mice. Sci Total Environ. 2021;790: 148041.","journal-title":"Sci Total Environ"},{"issue":"4","key":"5655_CR16","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1038\/s41418-020-00650-6","volume":"28","author":"L-Z Rao","year":"2021","unstructured":"Rao L-Z, Wang Y, Zhang L, et al. IL-24 deficiency protects mice against bleomycin-induced pulmonary fibrosis by repressing IL-4-induced M2 program in macrophages. Cell Death Differ. 2021;28(4):1270\u201383.","journal-title":"Cell Death Differ"},{"issue":"4","key":"5655_CR17","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1136\/jcp.41.4.467","volume":"41","author":"T Ashcroft","year":"1988","unstructured":"Ashcroft T, Simpson JM, Timbrell V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol. 1988;41(4):467\u201370.","journal-title":"J Clin Pathol"},{"issue":"12","key":"5655_CR18","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1164\/rccm.202010-3832OC","volume":"206","author":"F Ahangari","year":"2022","unstructured":"Ahangari F, Becker C, Foster DG, et al. Saracatinib, a Selective Src kinase inhibitor, blocks fibrotic responses in preclinical models of pulmonary fibrosis. Am J Respir Crit Care Med. 2022;206(12):1463\u201379.","journal-title":"Am J Respir Crit Care Med"},{"issue":"14","key":"5655_CR19","doi-asserted-by":"publisher","first-page":"7110","DOI":"10.7150\/thno.61085","volume":"11","author":"Q Wang","year":"2021","unstructured":"Wang Q, Liu J, Hu Y, et al. Local administration of liposomal-based Srpx2 gene therapy reverses pulmonary fibrosis by blockading fibroblast-to-myofibroblast transition. Theranostics. 2021;11(14):7110\u201325.","journal-title":"Theranostics"},{"issue":"3","key":"5655_CR20","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.7150\/thno.48152","volume":"11","author":"T Pan","year":"2021","unstructured":"Pan T, Zhou Q, Miao K, et al. Suppressing Sart1 to modulate macrophage polarization by siRNA-loaded liposomes: a promising therapeutic strategy for pulmonary fibrosis. Theranostics. 2021;11(3):1192\u2013206.","journal-title":"Theranostics"},{"issue":"2","key":"5655_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10280","volume":"7","author":"Y Mou","year":"2022","unstructured":"Mou Y, Wu G-R, Wang Q, et al. Macrophage-targeted delivery of siRNA to silence Mecp2 gene expression attenuates pulmonary fibrosis. Bioeng Transl Med. 2022;7(2): e10280.","journal-title":"Bioeng Transl Med"},{"issue":"10","key":"5655_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0223512","volume":"14","author":"M Negreros","year":"2019","unstructured":"Negreros M, Hagood JS, Espinoza CR, Balderas-Mart\u00ednez YI, Selman M, Pardo A. Transforming growth factor beta 1 induces methylation changes in lung fibroblasts. PLoS ONE. 2019;14(10): e0223512.","journal-title":"PLoS ONE"},{"issue":"24","key":"5655_CR23","doi-asserted-by":"publisher","first-page":"3982","DOI":"10.1093\/bioinformatics\/btx513","volume":"33","author":"Y Tian","year":"2017","unstructured":"Tian Y, Morris TJ, Webster AP, et al. ChAMP: updated methylation analysis pipeline for Illumina BeadChips. Bioinformatics. 2017;33(24):3982\u20134.","journal-title":"Bioinformatics"},{"issue":"2","key":"5655_CR24","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12742","volume":"53","author":"L Zhang","year":"2020","unstructured":"Zhang L, Wang Y, Wu G, et al. Blockade of JAK2 protects mice against hypoxia-induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation. Cell Prolif. 2020;53(2): e12742.","journal-title":"Cell Prolif"},{"key":"5655_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110715","volume":"131","author":"Q Wang","year":"2020","unstructured":"Wang Q, Yu J, Hu Y, et al. Indirubin alleviates bleomycin-induced pulmonary fibrosis in mice by suppressing fibroblast to myofibroblast differentiation. Biomed Pharmacother. 2020;131: 110715.","journal-title":"Biomed Pharmacother"},{"issue":"14","key":"5655_CR26","doi-asserted-by":"publisher","first-page":"6057","DOI":"10.7150\/thno.72328","volume":"12","author":"S Mei","year":"2022","unstructured":"Mei S, Xu Q, Hu Y, et al. Integrin \u03b23-PKM2 pathway-mediated aerobic glycolysis contributes to mechanical ventilation-induced pulmonary fibrosis. Theranostics. 2022;12(14):6057\u201368.","journal-title":"Theranostics"},{"issue":"12","key":"5655_CR27","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1164\/rccm.201504-0780OC","volume":"192","author":"N Xie","year":"2015","unstructured":"Xie N, Tan Z, Banerjee S, et al. Glycolytic Reprogramming in Myofibroblast Differentiation and Lung Fibrosis. Am J Respir Crit Care Med. 2015;192(12):1462\u201374.","journal-title":"Am J Respir Crit Care Med"},{"key":"5655_CR28","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.phrs.2015.04.012","volume":"97","author":"V Della Latta","year":"2015","unstructured":"Della Latta V, Cecchettini A, Del Ry S, Morales MA. Bleomycin in the setting of lung fibrosis induction: From biological mechanisms to counteractions. Pharmacol Res. 2015;97:122\u201330.","journal-title":"Pharmacol Res"},{"issue":"5","key":"5655_CR29","doi-asserted-by":"publisher","first-page":"96","DOI":"10.31083\/j.fbl2805096","volume":"28","author":"C-M Handra","year":"2023","unstructured":"Handra C-M, Gurzu I-L, Chirila M, Ghita I. Silicosis: New Challenges from an Old Inflammatory and Fibrotic Disease. Front Biosci (Landmark Ed). 2023;28(5):96.","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"9830","key":"5655_CR30","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/S0140-6736(12)60235-9","volume":"379","author":"CC Leung","year":"2012","unstructured":"Leung CC, Yu ITS, Chen W. Silicosis. Lancet. 2012;379(9830):2008\u201318.","journal-title":"Lancet"},{"issue":"2","key":"5655_CR31","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3109\/01902148.2014.979516","volume":"41","author":"JD Williamson","year":"2015","unstructured":"Williamson JD, Sadofsky LR, Hart SP. The pathogenesis of bleomycin-induced lung injury in animals and its applicability to human idiopathic pulmonary fibrosis. Exp Lung Res. 2015;41(2):57\u201373.","journal-title":"Exp Lung Res"},{"issue":"6","key":"5655_CR32","doi-asserted-by":"publisher","first-page":"L896","DOI":"10.1152\/ajplung.00084.2017","volume":"312","author":"HN Alsafadi","year":"2017","unstructured":"Alsafadi HN, Staab-Weijnitz CA, Lehmann M, et al. An ex vivo model to induce early fibrosis-like changes in human precision-cut lung slices. Am J Physiol Lung Cell Mol Physiol. 2017;312(6):L896\u2013902.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"5655_CR33","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1146\/annurev-pathol-042320-030240","volume":"17","author":"BJ Moss","year":"2022","unstructured":"Moss BJ, Ryter SW, Rosas IO. Pathogenic mechanisms underlying idiopathic pulmonary fibrosis. Annu Rev Pathol. 2022;17:515\u201346.","journal-title":"Annu Rev Pathol"},{"key":"5655_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107798","volume":"222","author":"P Spagnolo","year":"2021","unstructured":"Spagnolo P, Kropski JA, Jones MG, et al. Idiopathic pulmonary fibrosis: disease mechanisms and drug development. Pharmacol Ther. 2021;222: 107798.","journal-title":"Pharmacol Ther"},{"issue":"20","key":"5655_CR35","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.2217\/nnm-2017-0102","volume":"12","author":"F Movahedi","year":"2017","unstructured":"Movahedi F, Li L, Gu W, Xu ZP. Nanoformulations of albendazole as effective anticancer and antiparasite agents. Nanomedicine (Lond). 2017;12(20):2555\u201374.","journal-title":"Nanomedicine (Lond)"},{"issue":"5","key":"5655_CR36","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1136\/jitc-2021-003819","volume":"10","author":"L Zhu","year":"2022","unstructured":"Zhu L, Kuang X, Zhang G, et al. Albendazole induces immunotherapy response by facilitating ubiquitin-mediated PD-L1 degradation. J Immunother Cancer. 2022;10(5):7.","journal-title":"J Immunother Cancer"},{"key":"5655_CR37","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.canlet.2021.08.009","volume":"520","author":"H Yi","year":"2021","unstructured":"Yi H, Liang L, Wang H, et al. Albendazole inhibits NF-\u03baB signaling pathway to overcome tumor stemness and bortezomib resistance in multiple myeloma. Cancer Lett. 2021;520:307\u201320.","journal-title":"Cancer Lett"},{"issue":"3","key":"5655_CR38","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1111\/bjh.17557","volume":"194","author":"M Noura","year":"2021","unstructured":"Noura M, Morita K, Kiyose H, et al. Albendazole induces the terminal differentiation of acute myeloid leukaemia cells to monocytes by stimulating the Kr\u00fcppel-like factor 4-dihydropyrimidinase-like 2A (KLF4-DPYSL2A) axis. Br J Haematol. 2021;194(3):598\u2013603.","journal-title":"Br J Haematol"},{"issue":"3","key":"5655_CR39","first-page":"6","volume":"6","author":"MP Czubryt","year":"2019","unstructured":"Czubryt MP. Cardiac fibroblast to myofibroblast phenotype conversion-an unexploited therapeutic target. J Cardiovasc Dev Dis. 2019;6(3):6.","journal-title":"J Cardiovasc Dev Dis"},{"issue":"1","key":"5655_CR40","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s10020-022-00436-1","volume":"28","author":"C-T Liu","year":"2022","unstructured":"Liu C-T, Hsu S-C, Hsieh H-L, et al. Inhibition of \u03b2-catenin signaling attenuates arteriovenous fistula thickening in mice by suppressing myofibroblasts. Mol Med. 2022;28(1):7.","journal-title":"Mol Med"},{"issue":"1","key":"5655_CR41","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3390\/ijms21010201","volume":"21","author":"MB Morelli","year":"2019","unstructured":"Morelli MB, Shu J, Sardu C, Matarese A, Santulli G. Cardiosomal microRNAs are essential in post-infarction myofibroblast phenoconversion. Int J Mol Sci. 2019;21(1):56.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5655_CR42","doi-asserted-by":"publisher","first-page":"11350","DOI":"10.1038\/s41598-023-37776-9","volume":"13","author":"SA Pot","year":"2023","unstructured":"Pot SA, Lin Z, Shiu J, Benn MC, Vogel V. Growth factors and mechano-regulated reciprocal crosstalk with extracellular matrix tune the keratocyte-fibroblast\/myofibroblast transition. Sci Rep. 2023;13(1):11350.","journal-title":"Sci Rep"},{"issue":"6","key":"5655_CR43","first-page":"345","volume":"10","author":"H Luo","year":"2023","unstructured":"Luo H, Zhao L, Ou Z, Li T, Liu Y, Yu Z. Novel lncRNA LNC_000113 drives the activation of pulmonary adventitial fibroblasts through modulating PTEN\/Akt\/FoxO1 pathway. J Cardiovasc Dev Dis. 2023;10(6):345.","journal-title":"J Cardiovasc Dev Dis"},{"key":"5655_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107070","volume":"200","author":"D Peng","year":"2024","unstructured":"Peng D, Li J, Li Y, et al. MMP14high macrophages orchestrate progressive pulmonary fibrosis in SR-Ag-induced hypersensitivity pneumonitis. Pharmacol Res. 2024;200: 107070.","journal-title":"Pharmacol Res"},{"issue":"1","key":"5655_CR45","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s10020-023-00630-9","volume":"29","author":"R Xu","year":"2023","unstructured":"Xu R, Wu M, Wang Y, et al. Mesenchymal stem cells reversibly de-differentiate myofibroblasts to fibroblast-like cells by inhibiting the TGF-\u03b2-SMAD2\/3 pathway. Mol Med. 2023;29(1):59.","journal-title":"Mol Med"},{"issue":"5","key":"5655_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2023.188952","volume":"1878","author":"WY Su","year":"2023","unstructured":"Su WY, Tian LY, Guo LP, Huang LQ, Gao WY. PI3K signaling-regulated metabolic reprogramming: From mechanism to application. Biochim Biophys Acta Rev Cancer. 2023;1878(5): 188952.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"1\u20132","key":"5655_CR47","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s11010-016-2927-3","volume":"428","author":"F Zhou","year":"2017","unstructured":"Zhou F, Du J, Wang J. Albendazole inhibits HIF-1\u03b1-dependent glycolysis and VEGF expression in non-small cell lung cancer cells. Mol Cell Biochem. 2017;428(1\u20132):171\u20138.","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"5655_CR48","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41531-023-00527-8","volume":"9","author":"X Guo","year":"2023","unstructured":"Guo X, Hu W, Gao Z, Fan Y, Wu Q, Li W. Identification of PLOD3 and LRRN3 as potential biomarkers for Parkinson\u2019s disease based on integrative analysis. NPJ Parkinsons Dis. 2023;9(1):82.","journal-title":"NPJ Parkinsons Dis"},{"key":"5655_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2023.115767","volume":"269","author":"Y Lu","year":"2024","unstructured":"Lu Y, Mu M, RenChen X, et al. 2-Deoxy-D-glucose ameliorates inflammation and fibrosis in a silicosis mouse model by inhibiting hypoxia-inducible factor-1\u03b1 in alveolar macrophages. Ecotoxicol Environ Saf. 2024;269: 115767.","journal-title":"Ecotoxicol Environ Saf"},{"issue":"1","key":"5655_CR50","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1183\/13993003.00026-2015","volume":"47","author":"PW Noble","year":"2016","unstructured":"Noble PW, Albera C, Bradford WZ, et al. Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials. Eur Respir J. 2016;47(1):243\u201353.","journal-title":"Eur Respir J"},{"issue":"22","key":"5655_CR51","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","volume":"370","author":"L Richeldi","year":"2014","unstructured":"Richeldi L, du Bois RM, Raghu G, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med. 2014;370(22):2071\u201382.","journal-title":"N Engl J Med"},{"issue":"3","key":"5655_CR52","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/0304-4017(89)90017-4","volume":"30","author":"RK Sharma","year":"1989","unstructured":"Sharma RK, Singh K, Saxena KK. The effect of levamisole and albendazole on some enzymes of Ascaridia galli and Heterakis gallinae. Vet Parasitol. 1989;30(3):213\u201322.","journal-title":"Vet Parasitol"},{"issue":"2","key":"5655_CR53","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202302063RR","volume":"38","author":"Z Sun","year":"2024","unstructured":"Sun Z, Ji Z, He W, Duan R, Qu J, Yu G. Lactate accumulation induced by Akt2-PDK1 signaling promotes pulmonary fibrosis. FASEB J. 2024;38(2): e23426.","journal-title":"FASEB J"},{"issue":"1","key":"5655_CR54","doi-asserted-by":"publisher","first-page":"5449","DOI":"10.1038\/s41467-024-49545-x","volume":"15","author":"AA Raslan","year":"2024","unstructured":"Raslan AA, Pham TX, Lee J, et al. Lung injury-induced activated endothelial cell states persist in aging-associated progressive fibrosis. Nat Commun. 2024;15(1):5449.","journal-title":"Nat Commun"},{"issue":"1","key":"5655_CR55","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s13148-020-00951-0","volume":"12","author":"SCE Maas","year":"2020","unstructured":"Maas SCE, Mens MMJ, K\u00fchnel B, et al. Smoking-related changes in DNA methylation and gene expression are associated with cardio-metabolic traits. Clin Epigenetics. 2020;12(1):157.","journal-title":"Clin Epigenetics"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05655-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-024-05655-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05655-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T07:08:00Z","timestamp":1728371280000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-024-05655-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,7]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5655"],"URL":"https:\/\/doi.org\/10.1186\/s12967-024-05655-0","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,7]]},"assertion":[{"value":"24 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in compliance with the Declaration of Helsinki and was approved by the Human Assurance Committee of Tongji Hospital (TJ-IRB20210942). All experimental procedures were approved by the Animal Care and Use Committee of Tongji Hospital (TJH-202210029).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests. All authors have carefully reviewed and complied with the journal\u2019s authorship agreement.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"910"}}